Who
In numbers
- Trades disclosed
- 23
- Buys
- 2
- Sells
- 0
- Bought
- $398K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 26 May 2022
- Last trade
- 12 May 2026
- Last filed
- 13 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 13 May 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —31,481 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —31,481 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 13 May 2025filed 14 May 2025 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —17,989 at $0.00 | filing |
| 13 May 2025filed 14 May 2025 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —104,547 at $0.00 | filing |
| 17 Mar 2025filed 18 Mar 2025 | BTMD BiotePharmaceuticals | SEC FORM 4 Bought | $148K38,104 at $3.88 | filing |
| 21 May 2024filed 23 May 2024 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,828 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —65,258 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,058 | filing |
| 30 Jun 2023filed 5 Jul 2023 | BTMD BiotePharmaceuticals | SEC FORM 4 Code M | —6,058 | filing |
| 17 May 2023filed 19 May 2023 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,524 at $0.00 | filing |
| 17 May 2023filed 19 May 2023 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —46,809 at $0.00 | filing |
| 31 Mar 2023filed 4 Apr 2023 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —9,844 | filing |
| 31 Mar 2023filed 4 Apr 2023 | BTMD BiotePharmaceuticals | SEC FORM 4 Code M | —9,844 | filing |
| 9 Jan 2023filed 10 Jan 2023 | BTMD BiotePharmaceuticals | SEC FORM 4 Bought | $250K83,350 at $3.00 | filing |
| 31 Dec 2022filed 4 Jan 2023 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —9,844 | filing |
| 31 Dec 2022filed 4 Jan 2023 | BTMD BiotePharmaceuticals | SEC FORM 4 Code M | —9,844 | filing |
| 15 Nov 2022filed 18 Nov 2022 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —31,696 at $0.00 | filing |
| 15 Nov 2022filed 16 Nov 2022 | BTMD Bioteoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —31,696 at $0.00 | filing |
News
Clover Health Investments (NASDAQ:CLOV) vs. biote (NASDAQ:BTMD) Financial AnalysisBTMD · themarketsdaily.com · 15 Oct 2026Hims & Hers Health (NYSE:HIMS) vs. biote (NASDAQ:BTMD) Head-To-Head ContrastBTMD · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Stephen Mark Cone; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.